As part of Tabuk’s growth strategy in the gulf region, Tabuk has successfully launched Winex®; Cefixime a third generation oral cephalosporin in UAE and Qatar. Oral cephalosporins market in UAE is bustling with $22 million in MAT/03/2008, with an average growth rate of 19%.
Qatar’s oral cephalosporin market is approximately 4 million USD, and we are planning for a ceremony launch soon.